<DOC>
	<DOCNO>NCT00004480</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine optimal dose botulinum toxin necessary decrease sweat patient primary hyperhidrosis .</brief_summary>
	<brief_title>Study Botulinum Toxin Patients With Primary Hyperhidrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive injection botulinum toxin clinical trial 6 month . Patients undergo iodine starch test sympathetic skin response test ass efficacy drug . Patients also complete questionnaire evaluate amount sweating .</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis hyperhidrosis Excessive sweating hand , foot , armpit , forehead , body</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>dermatologic disorder</keyword>
	<keyword>hyperhidrosis</keyword>
	<keyword>rare disease</keyword>
</DOC>